Please use this identifier to cite or link to this item:
Full metadata record
|dc.contributor.other||University of Hawaii at Manoa||en_US|
|dc.contributor.other||Faculty of Medicine, Siriraj Hospital, Mahidol University||en_US|
|dc.contributor.other||Chiang Mai University||en_US|
|dc.contributor.other||Bassett Medical Center||en_US|
|dc.identifier.citation||Saudi Journal of Gastroenterology. Vol.24, No.1 (2018), 12-17||en_US|
|dc.description.abstract||© 2018 Saudi Journal of Gastroenterology Published by Wolters Kluwer-Medknow. Background/Aim: The association between sarcopenia and nonalcoholic fatty liver disease (NAFLD) has been suggested by recent epidemiological studies, although the results have been inconsistent. This meta-analysis was conducted to summarize all available data and estimate the risk of NAFLD among patients with sarcopenia. Materials and Methods: A comprehensive literature review was conducted using MEDLINE and EMBASE databases through November 2016 to identify all studies that compared the risk of NAFLD among patients with sarcopenia versus those without sarcopenia. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: Five cross-sectional studies with 27,804 participants met the eligibility criteria and were included in the meta-analysis. The risk of NAFLD in patients with sarcopenia was significantly higher than those without sarcopenia with the pooled odds ratio of 1.54 (95% confidence interval, 1.05-2.26). The statistical heterogeneity was high with an I 2 of 83%. Conclusions: A significantly increased risk of NAFLD among patients with sarcopenia was observed in this study.||en_US|
|dc.title||Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis||en_US|
|Appears in Collections:||Scopus 2018|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.